Post-earnings recap
Reported
Thu, Aug 6, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytomX Therapeutics reported a loss of $0.34 per share, significantly missing expectations. Despite this, the stock rose by 1.34%, which may indicate investor optimism or a reaction to other factors not disclosed in the earnings call.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.34 | N/A | -201.19% |
| Revenue | $0 | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.